Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through gh resistance in chondrocytes

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages E2198-E2206

  Guasti, Leonardo ^a   Silvennoinen, Sanna ^b   Bulstrode, Neil W ^c   Ferretti, Patrizia ^d   Sankilampi, Ulla ^b   Dunkel, Leo ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GROWTH HORMONE; SOMATOMEDIN C; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; FIBROBLAST GROWTH FACTOR; HUMAN GROWTH HORMONE;

ALP GENE; ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COHORT ANALYSIS; COLII GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GROWTH DISORDER; GROWTH REGULATION; HORMONE INHIBITION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IGF1 GENE; IN VITRO STUDY; INFANT; MALE; POSTNATAL LINEAR GROWTH; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOCS2 GENE; BLOOD; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; CHONDROCYTES; FEMALE; FIBROBLAST GROWTH FACTORS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, PREMATURE; MALE; SIGNAL TRANSDUCTION;

EID: 84909993520     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1566     Document Type: Article

References (35)

1. Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003;112(1 Pt 1): e30-e38.
2. Wehkalampi K, Hovi P, Dunkel L, et al. Advanced pubertal growth spurt in subjects born preterm: the Helsinki study of very low birth weight adults. J Clin Endocrinol Metab. 2011;96(2): 525-533.
3. Mehta A, Hindmarsh PC, Stanhope RG, et al. The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a model. Clin Endocrinol (Oxf). 2005;63(2): 223-231.
4. Kajantie E, Dunkel L, Rutanen EM, et al. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab. 2002;87(5): 2171-2179.
5. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab. 1998;83(10): 3550-3557.
6. Deiber M, Chatelain P, Naville D, Putet G, Salle B. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab. 1989;68(1): 232-234.
7. Kubicky RA, Wu S, Kharitonenkov A, De Luca F. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology. 2012;153(5): 2287-2295.
8. Wu S, Levenson A, Kharitonenkov A, De Luca F. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem. 2012; 287(31): 26060-26067.
9. Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metab. 2012;16(6): 693-705.
10. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fastinginduced hormone FGF21. Cell Metab. 2008;8(1): 77-83.
11. Yang C, Jin C, Li X, Wang F, McKeehan WL, Luo Y. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. PLoS One. 2012;7(3): e33870.
12. Ding X, Boney-Montoya J, Owen BM, et al. betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 2012;16(3): 387-393.
13. Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004; 114(5): 1305-1311.
14. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. Report on the guidelines on parenteral nutrition in infants, children and adolescents. Clin Nutr. 2005;24(6): 1105-1109.
15. Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50(1): 85-91.
16. Sankilampi U, Hannila ML, Saari A, Gissler M, Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med. 2013;45(5-6): 446-454.
17. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P; International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111(6 Pt 1): 1253-1261.
18. Guasti L, Prasongchean W, Kleftouris G, et al. High plasticity of pediatric adipose tissue-derived stem cells: too much for selective skeletogenic differentiation? Stem Cells Transl Med. 2012;1(5): 384-395.
19. Guasti L, Vagaska B, BulstrodeNW, SeifalianAM, Ferretti P. Chondrogenic differentiation of adipose tissue-derived stem cells within nanocaged POSS-PCU scaffolds: a new tool for nanomedicine. Nanomedicine. 2014;10(2): 279-289.
20. Gevers EF, Hannah MJ, Waters MJ, Robinson IC. Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. Endocrinology. 2009;150(8): 3627-3636.
21. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res. 2002;17(8): 1408-1419.
22. Vesterlund M, Zadjali F, Persson T, et al. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One. 2011;6(9): e25358.
23. MaorG, Hochberg Z, von derMarkK, Heinegard D, SilbermannM. Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology. 1989;125(3): 1239-1245.
24. Safran M, Eisenstein M, Aviezer D, Yayon A. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2. Biochem J. 2000;345(Pt 1): 107-113.
25. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992;9(3): 383-391.
26. Spivak-Kroizman T, Lemmon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell. 1994;79(6): 1015-1024.
27. Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics. 1999;104(2 Pt 1): 280-289.
28. Niklasson A, Engstrom E, Hard AL, Wikland KA, Hellstrom A. Growth in very preterm children: a longitudinal study. Pediatr Res. 2003;54(6): 899-905.
29. Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003;111(5 Pt 1): 986-990.
30. Berry MA, Conrod H, Usher RH. Growth of very premature infants fed intravenous hyperalimentation and calcium-supplemented formula. Pediatrics. 1997;100(4): 647-653.
31. Marks KA, Reichman B, Lusky A, Zmora E. Fetal growth and postnatal growth failure in very-low-birthweight infants. Acta Paediatr. 2006;95(2): 236-242.
32. Mayer M, Schmitt K, Kapelari K, Frisch H, Köstl G, Voigt M. Spontaneous growth in growth hormone deficiency from birth until 7 years of age: development of disease-specific growth curves. Horm Res Paediatr. 2010;74(2): 136-144.
33. Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathicGHDeficiency: analysis of data from KIGS. J Clin Endocrinol Metab. 2005;90(4): 1966-1971.
34. Deng L, He K, Wang X, et al. Determinants of growth hormone receptor down-regulation. Mol Endocrinol. 2007;21(7): 1537-1551.
35. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229(1): 141-162.